Promotion of Corneal Allograft Survival by the Induction of Oxidative Macrophages

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 2, 2004, Pages 448-454

  Yamada, Jun ^a,b   Maruyama, Kazuichi ^b   Sano, Yoichiro ^b   Kinoshita, Shigeru ^b   Murata, Yukie ^c   Hamuro, Junji ^c  

^a MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE DERIVATIVE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 4; N,N' DIACETYLCYSTEINE DIMETHYL ESTER; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POLARITY; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; GRAFT SURVIVAL; IMMUNE RESPONSE; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADOPTIVE TRANSFER; ANIMALS; CELL DIVISION; CORNEA; CORNEAL TRANSPLANTATION; CYSTINE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; OXIDATION-REDUCTION; TH1 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0942265589     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0939     Document Type: Article

References (43)

1. Maumenee AE. The influence of donor-recipient sensitization on corneal grafts. Am J Ophthalmol. 1951;34:142-152.
2. The Collaborative Corneal Transplantation Studies Research Group. The Collaborative Corneal Transplantation Studies (CCTS): effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol. 1992;110:1392-1403.
3. Maguire MG, Stark WJ, Gottsch JD, et al. The Collaborative Corneal Transplantation Studies Research Group: risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology. 1994;101:1536-1547.
4. Mader TH, Stulting RD. The high-risk penetrating keratoplasty. Ophthalmol Clin North Am. 1991;4:411-426.
5. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 1991;32:2723-2728.
6. Joo CK, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci. 1995;36:1530-1540.
7. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell. 1994;76:241-251.
8. Slegers TP, Torres PF, Broersma L, van Rooijen N, van Rij G, van der Gaag R. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats. Invest Ophthalmol Vis Sci. 2000;41:2239-2247.
9. Sano Y, Okamoto S, Streilein JW. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes. Curr Eye Res. 1997;16:1171-1174.
10. Meister A. Glutathione Centennial: Molecular Properties and Clinical Applications. New York: Academic Press; 1989.
11. Murata Y, Yamashita A, Saito T, Sugamura K, Hamuro J. The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice. Int Immunol. 2002;14:627-636.
12. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA. 1998;95:3071-3076.
13. Murata Y, Amao M, Yoneda J, Hamuro J. Intracellular thiol redox status of macrophages directs the Th1 skewing in thioredoxin transgenic mice during aging. Mol Immunol. 2002;38:747-757.
14. Murata Y, Shimamura T, Hamuro J. The polarization of T(h)1/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol. 2002;14:201-212.
15. Utsugi M, Dobashi K, Koga Y, et al. Glutathione redox regulates lipopolysaccharide-induced IL-12 production through p38 mitogen-activated protein kinase activation in human monocytes: role of glutathione redox in IFN-gamma priming of IL-12 production. J Leukocyte Biol. 2002;71:339-347.
16. Utsugi M, Dobashi K, Ishizuka T, et al. c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. J Immunol. 2003;171:628-635.
17. Mackaness GB. The immunological basis of acquired cellular resistance. J Exp Med. 1964;120:105-120.
18. Murata Y, Amao M, Hamuro J. Sequential conversion of the redox status of macrophages dictates the pathological progression of autoimmune diabetes. Eur J Immunol. 2003;33:1001-1011.
19. Murata Y, Ohteki T, Koyasu S, Hamuro J. IFN-gamma and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur J Immunol. 2002;32:2866-2873.
20. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci. 1995;36:2176-2185.
21. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694-704.
22. Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 1992;11:1199-1206.
23. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol. 1992;22:165-173.
24. Yamada J, Yoshida M, Taylor AW, Streilein JW. Mice with Th2-biased immune systems accept orthotopic corneal aflografts placed in "high risk" eyes. J Immunol. 1999;162:5247-5255.
25. Sano Y, Osawa H, Sotozono C, Kinoshita S. Cytokine expression during orthotopic corneal allograft rejection in mice. Invest Ophthalmol Vis Sci. 1998;39:1953-1957.
26. Hamrah P, Zhang Q, Liu Y, Dana MR. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-tye dendritic cells. Invest Ophthalmol Vis Sci. 2002;43:639-646.
27. Brissette-Storkus CS, Reynolds SM, Lepisto AJ, Hendricks RL. Identification of a novel macrophage population in the normal mouse corneal stroma. Invest Ophthalmol Vis Sci. 2002;43:2264-2271.
28. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol. 1984;2:283-318.
29. Muzio M, Polentarutti N, Bosisio D, Manoj Kumar PP, Mantovani A. Toll-like receptor family and signalling pathway. Biochem Soc Trans. 2000;28:563-566.
30. Means TK, Golenbock DT, Fenton MJ. Structure and function of Toll-like receptor proteins. Life Sci. 2000;68:241-258.
31. Kaisho T, Akira S. Critical roles of Toll-like receptors in host defense. Crit Rev Immunol. 2000;20:393-405.
32. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166-6173.
33. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol. 1998;160:5347-5354.
34. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity. 1999;10:137-142.
35. Shearer JD, Richards JR, Mills CD, Caldwell MD. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol. 1997;272:E181-E190.
36. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23-35.
37. Torres PF, Slegers TP, Peek R, et al. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment. Invest Ophthalmol Vis Sci. 1999;40:3194-3201.
38. Brewer JM, Richmond J, Alexander J. The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies. Clin Exp Immunol. 1994;97:164-171.
39. Desmedt M, Rottiers P, Dooms H, Fiers W, Grooten J. Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J Immunol. 1998;160:5300-5308.
40. Sano Y, Ksander BR, Streilein JW. Murine orthotopic corneal transplantation in high-risk eyes: rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci. 1997;38:1130-1138.
41. Ma D, Mellon J, Niederkorn JY. Oral immunisation as a strategy for enhancing corneal allograft survival. Br J Ophthalmol. 1997;81:778-784.
42. Yamagami S, Tsuru T, Isobe M, Obata H, Suzuki J. The role of cell adhesion molecules in allograft rejection after penetrating keratoplasty in mice: clinical and immunohistochemical study. Graefes Arch Clin Exp Ophthalmol. 1996;234:382-387.
43. Qian Y, Boisgerault F, Benichou G, Dana MR. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Invest Ophthalmol Vis Sci. 2001;42:987-994.